
Kolosis Attends 2026 Spine Summit
The Kolosis team will be attending the 2026 Spine Summit
Leverage Established GPO and IDN Agreements through MTF.
The Biggest Technologies in biologics delivered to you.
It’s Time to Upgrade your Orthobiologics Options
Kore Fiber approved in over 80 health systems
Kolosis bone grafts on shelf in more than 550 facilities
In past 12 months, Kore and Prime HD utilized
in over 22,000 fusion procedures
Kolosis grafts on hospital shelves in Canada
and 48 US states
International distribution footprint with over 250 independent distributors
APEXecm is a next-generation, 100% allogenic extracellular Mini Tile Matrix from Kolosis, designed to optimize the wound healing environment.1
For decades, DBX has been a trusted name in DBM, earning its reputation through years of proven performance in both preclinical animal models and in clinical studies.1
A 100% demineralized cortical bone allograft engineered to address the complex demands of sternal fusion.
MTF’s proprietary aseptic processing ensures preservation of key biological matrices and vital matrix proteins.1
Allograft membrane designed to help with optimizing surgical outcomes and reducing complications in poor healing patients.

The Kolosis team will be attending the 2026 Spine Summit

Kolosis was honored to attend the 2026 Life Sciences Day

The Kolosis team will be attending the 2026 STS (Society